These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2319516)

  • 1. Intravenous pulsed steroids in rheumatoid arthritis: a comparative dose study.
    Iglehart IW; Sutton JD; Bender JC; Shaw RA; Ziminski CM; Holt PA; Hochberg MC; Zizic TM; Engle EW; Stevens MB
    J Rheumatol; 1990 Feb; 17(2):159-62. PubMed ID: 2319516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three pulse methylprednisolone regimens in the treatment of rheumatoid arthritis.
    Radia M; Furst DE
    J Rheumatol; 1988 Feb; 15(2):242-6. PubMed ID: 3283356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.
    Durez P; Nzeusseu Toukap A; Lauwerys BR; Manicourt DH; Verschueren P; Westhovens R; Devogelaer JP; Houssiau FA
    Ann Rheum Dis; 2004 Sep; 63(9):1069-74. PubMed ID: 15308515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
    Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
    Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis--a randomized, double blind 26-week trial.
    Morassut P; Goldstein R; Cyr M; Karsh J; McKendry RJ
    J Rheumatol; 1989 Mar; 16(3):302-6. PubMed ID: 2498513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of Sharp's index in the clinical and laboratory response to an intravenous methylprednisolone pulse in patients with rheumatoid arthritis].
    Cuchacovich M; Gatica H; Muñoz S; González P
    Rev Med Chil; 2000 Mar; 128(3):301-8. PubMed ID: 10962872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study.
    Frediani B; Falsetti P; Bisogno S; Baldi F; Acciai C; Filippou G; Bacarelli MR; Filipponi P; Galeazzi M; Marcolongo R
    J Rheumatol; 2004 Jun; 31(6):1083-7. PubMed ID: 15170918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
    Williams GW; Kivitz AJ; Brown MT; Verburg KM
    Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulsed suppressive treatment in rheumatoid arthritis: intravenous methylprednisolone and nitrogen mustard.
    Danao T; Segal AM
    J Rheumatol; 1990 Jul; 17(7):893-9. PubMed ID: 2213755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
    Rau R; Sander O; van Riel P; van de Putte L; Hasler F; Zaug M; Kneer J; van der Auwera P; Stevens RM;
    J Rheumatol; 2003 Apr; 30(4):680-90. PubMed ID: 12672184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of administration of a series of methylprednisolone minipulses in the treatment of active rheumatoid arthritis].
    Hrncír Z
    Cas Lek Cesk; 1994 Jul; 133(14):440-2. PubMed ID: 8069902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etodolac versus diclofenac: double-blind cross-over study in rheumatoid arthritis.
    Ciompi ML; Puccetti L; Bazzichi L; Remorini E; Marotta G
    Int J Clin Pharmacol Res; 1989; 9(3):217-22. PubMed ID: 2526101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
    Quinn MA; Green MJ; Marzo-Ortega H; Proudman S; Karim Z; Wakefield RJ; Conaghan PG; Emery P
    Arthritis Rheum; 2003 Nov; 48(11):3039-45. PubMed ID: 14613264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
    Choy EH; Isenberg DA; Garrood T; Farrow S; Ioannou Y; Bird H; Cheung N; Williams B; Hazleman B; Price R; Yoshizaki K; Nishimoto N; Kishimoto T; Panayi GS
    Arthritis Rheum; 2002 Dec; 46(12):3143-50. PubMed ID: 12483717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized study.
    Caldwell JR; Furst DE; Smith AL; Clark JA; Bonebrake RA; Gruhn WB; McIlwain HH; Logue CM
    J Rheumatol; 1998 Jan; 25(1):30-5. PubMed ID: 9458199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis.
    Berg KJ; Førre O; Djøseland O; Mikkelsen M; Narverud J; Rugstad HE
    Clin Nephrol; 1989 May; 31(5):232-8. PubMed ID: 2661065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.